Ketamine may keep kids with sickle cell out of the hospital
NCT ID NCT07450430
First seen Mar 06, 2026 · Last updated May 20, 2026 · Updated 4 times
Summary
This study tests whether giving ketamine early (within one hour of arriving at the hospital) can help children and young adults with sickle cell disease avoid being admitted for pain. Participants aged 6 to 24 will receive either ketamine or a placebo by mouth. If they are admitted, they can still receive standard IV ketamine later. The study will also check if starting ketamine early reduces the need for other pain medicines and shortens hospital stays.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Boston Children's Hospital
Brookline, Massachusetts, 02445, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.